Valuation: The ACME Laboratories Ltd.

Market Cap 17.44B 141M 124M 114M 105M 199M 13.63B 202M 1.37B 537M 6.67B 531M 519M 22.97B P/E 2024
5.9x
P/E 2025 6.29x
Enterprise Value 40.31B 327M 286M 265M 243M 459M 31.5B 467M 3.16B 1.24B 15.41B 1.23B 1.2B 53.1B EV / Sales 2024
1.15x
EV / Sales 2025 1.06x
Free-Float
55.88%
Yield 2024
5.11%
Yield 2025 4.85%
1 day+0.36%
1 week-1.40%
Current month+2.31%
1 month+2.68%
3 months+11.51%
6 months+14.85%
Current year+18.90%
1 week 83.1
Extreme 83.1
87.5
1 month 79.6
Extreme 79.6
88.7
Current year 70.6
Extreme 70.6
88.7
1 year 68.6
Extreme 68.6
88.7
3 years 62.6
Extreme 62.6
94.5
5 years 62.6
Extreme 62.6
117.7
10 years 54.2
Extreme 54.2
122.5
Manager TitleAgeSince
Chief Executive Officer 82 1995-09-29
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 82 1975-03-16
Director/Board Member 76 1981-04-14
Chairman 69 2018-09-04
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%-1.40%+12.25%-1.17% 144M
-1.75%-1.59%+52.60%+150.76% 1,051B
-1.47%-3.05%+52.04%+48.41% 609B
-0.44%+2.11%+36.99%+78.09% 450B
-0.75%+0.30%+29.77%+21.15% 330B
-1.52%-1.19%+34.46%+35.35% 284B
-1.70%-1.82%+20.99%+15.74% 263B
-0.58%+1.11%-20.18%-40.59% 223B
-0.31%+1.34%+23.46%+56.62% 198B
-0.64%+1.69%+23.40%+67.14% 167B
Average -0.84%+0.20%+26.58%+43.15% 357.52B
Weighted average by Cap. -1.15%+0.02%+37.15%+72.05%

Financials

2024 2025
Net sales 31.93B 259M 227M 210M 193M 364M 24.95B 370M 2.51B 983M 12.21B 972M 950M 42.06B 35.94B 291M 255M 236M 217M 409M 28.08B 416M 2.82B 1.11B 13.74B 1.09B 1.07B 47.34B
Net income 2.46B 19.9M 17.45M 16.13M 14.83M 27.98M 1.92B 28.43M 193M 75.59M 939M 74.74M 73.11M 3.24B 2.43B 19.68M 17.25M 15.95M 14.66M 27.67M 1.9B 28.11M 191M 74.74M 929M 73.9M 72.29M 3.2B
Net Debt 22.18B 180M 158M 146M 134M 253M 17.33B 257M 1.74B 683M 8.48B 675M 660M 29.22B 22.87B 185M 162M 150M 138M 261M 17.87B 265M 1.8B 704M 8.75B 696M 681M 30.13B
Logo The ACME Laboratories Ltd.
The ACME Laboratories Limited is a Bangladesh-based company, which is engaged in manufacturing, marketing, and distribution of pharmaceuticals formulation products. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products, which include human drugs comprising dosages like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, and sachet products. It also offers veterinary drugs comprising dosages like bolus, liquid, injection, water-soluble powder, premix, and herbal drugs comprising dosages like liquid, capsule, tablet, cream, and ointment. The products of the Company are sold in domestic and international markets, respectively. Its factory is situated at Dhulivita, Dhamrai, Dhaka, and Bangladesh. It produces approximately 800 products in different dosage forms.
Employees
9,025
Date Price Change Volume
26-07-19 BDT 84.30 +0.36% 357,746
26-07-19 BDT 84.00 -1.52% 749,927
26-07-16 BDT 85.30 -1.27% 920,682
26-07-15 BDT 86.40 -0.46% 1,276,664
26-07-14 BDT 86.80 -0.12% 1,312,285
  1. Stock Market
  2. Stocks
  3. ACMELAB Stock